Bradley J Beattie

Years Active: 2020-2022
Publications (10 Years): 3

This page only lists publications with an associated author ORCID identifier.

Publications

Abbie Hasson, Wen Jiang, Nadia Benabdallah, Peng Lu, Mark S Longtine, Bradley J Beattie, Lucy Summer, Hanwen Zhang, Richard L Wahl, Diane S Abou, Daniel L J Thorek
Radiochemical Quality Control Methods for Radium-223 and Thorium-227 Radiotherapies. Cancer biotherapy & radiopharmaceuticals (2022)
Bradley J Beattie, Tim J Akhurst, Finn Augensen, John L Humm
SUVfdg: A standard-uptake-value (SUV) body habitus normalizer specific to fluorodeoxyglucose (FDG) in humans. PloS one 17 (4) (2022)
Mark P S Dunphy, Christina Pressl, Nagavarakishore Pillarsetty, Milan Grkovski, Shanu Modi, Komal Jhaveri, Larry Norton, Bradley J Beattie, Pat B Zanzonico, Danuta Zatorska, Tony Taldone, Stefan O Ochiana, Mohammad M Uddin, Eva M Burnazi, Serge K Lyashchenko, Clifford A Hudis, Jacqueline Bromberg, Heiko M Schöder, Josef J Fox, Hanwen Zhang, Gabriela Chiosis, Jason S Lewis, Steven M Larson
First-in-Human Trial of Epichaperome-Targeted PET in Patients with Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (19) (2020)

Bradley J Beattie.css-eqlu8i{font-size:small;padding-left:4px;}